CD163 and peripheral arterial disease: The ratio between plasma levels of macrophage scavenger receptor CD163 and tumor necrosis factor-like weak inducer of apoptosis (TWEAK) was also shown to be a potential biomarker of athero-thrombosis in asymptomatic PAD subjects [80].